Danaher
stock was rising Tuesday after the healthcare company reported third-quarter earnings and revenue that topped Wall Street estimates.
Danaher
(ticker: DHR) reported earnings for the third quarter ended Sept. 29, of $2.02 a share on revenue of $6.87 billion. That beat analyst estimates of $1.81 a share on revenue of $6.6 billion.
In the same period last year, the company reported earnings of $2.56 a share on revenue of $7.66 billion.
“Revenue in the third quarter came in ahead of our expectations, with biotechnology performing as anticipated, and higher respiratory testing revenue more than offsetting slightly softer-than-anticipated demand in life sciences,” Chief Executive Rainer Blair said in a press release.
Danaher
also said for fiscal 2023, it anticipates that non-GAAP base business core revenue from continuing operations will be down slightly year-over-year.
Danaher shares were rising 1.2% in premarket trading to $206.50. Coming into the session, the stock has dropped 13% this year.
Write to Angela Palumbo at [email protected]
Read the full article here
